DYN logo

Dyne Therapeutics (DYN) Company Overview

Profile

Full Name:

Dyne Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 17, 2020

Indexes:

Not included

Description:

Dyne Therapeutics is a biotechnology company focused on developing innovative therapies for serious muscle diseases. They use their proprietary technology to create treatments that target and improve muscle function, aiming to enhance the quality of life for patients with genetic disorders affecting muscles.

Events Calendar

Earnings

Next earnings date:

Mar 5, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 24, 25 Guggenheim
Buy
Jan 14, 25 RBC Capital
Outperform
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 10, 25 Chardan Capital
Buy
Dec 13, 24 Baird
Outperform
Nov 26, 24 RBC Capital
Outperform
Nov 13, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Chardan Capital
Buy
Oct 24, 24 JP Morgan
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Dyne Therapeutics?
  • Does Dyne Therapeutics pay dividends?
  • What sector is Dyne Therapeutics in?
  • What industry is Dyne Therapeutics in?
  • What country is Dyne Therapeutics based in?
  • When did Dyne Therapeutics go public?
  • Is Dyne Therapeutics in the S&P 500?
  • Is Dyne Therapeutics in the NASDAQ 100?
  • Is Dyne Therapeutics in the Dow Jones?
  • When was Dyne Therapeutics's last earnings report?
  • When does Dyne Therapeutics report earnings?
  • Should I buy Dyne Therapeutics stock now?

What is the ticker symbol for Dyne Therapeutics?

The ticker symbol for Dyne Therapeutics is NASDAQ:DYN

Does Dyne Therapeutics pay dividends?

No, Dyne Therapeutics does not pay dividends

What sector is Dyne Therapeutics in?

Dyne Therapeutics is in the Healthcare sector

What industry is Dyne Therapeutics in?

Dyne Therapeutics is in the Biotechnology industry

What country is Dyne Therapeutics based in?

Dyne Therapeutics is headquartered in United States

When did Dyne Therapeutics go public?

Dyne Therapeutics's initial public offering (IPO) was on September 17, 2020

Is Dyne Therapeutics in the S&P 500?

No, Dyne Therapeutics is not included in the S&P 500 index

Is Dyne Therapeutics in the NASDAQ 100?

No, Dyne Therapeutics is not included in the NASDAQ 100 index

Is Dyne Therapeutics in the Dow Jones?

No, Dyne Therapeutics is not included in the Dow Jones index

When was Dyne Therapeutics's last earnings report?

Dyne Therapeutics's most recent earnings report was on Nov 12, 2024

When does Dyne Therapeutics report earnings?

The next expected earnings date for Dyne Therapeutics is Mar 5, 2025

Should I buy Dyne Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions